Global Retirement Partners’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$264 Buy
+22
New +$183 ﹤0.01% 4357
2025
Q4
$317 Hold
22
﹤0.01% 4066
2025
Q3
$212 Hold
22
﹤0.01% 3735
2025
Q2
$181 Buy
+22
New +$184 ﹤0.01% 3680
2024
Q4
$3.07K Hold
397
﹤0.01% 2910
2024
Q3
$4.17K Hold
397
﹤0.01% 2649
2024
Q2
$4.64K Hold
397
﹤0.01% 2647
2024
Q1
$8.37K Buy
397
+375
+1,705% +$6.67K ﹤0.01% 2200
2023
Q4
$336 Hold
22
﹤0.01% 3159
2023
Q3
$334 Hold
22
﹤0.01% 3045
2023
Q2
$440 Hold
22
﹤0.01% 2975
2023
Q1
$445 Hold
22
﹤0.01% 2947
2022
Q4
$499 Hold
22
﹤0.01% 2758
2022
Q3
$1K Hold
22
﹤0.01% 2562
2022
Q2
$1K Hold
22
﹤0.01% 2535
2022
Q1
$0 Buy
+22
New +$611 ﹤0.01% 2752
2020
Q4
Sell
-165
Closed -$5K 1790
2020
Q3
$5K Hold
165
﹤0.01% 1332
2020
Q2
$6K Hold
165
﹤0.01% 1257
2020
Q1
$5K Hold
165
﹤0.01% 1243
2019
Q4
$7K Buy
+165
New +$6.52K ﹤0.01% 1251

Other funds holding RGNX

Global Retirement Partners's RGNX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Regenxbio (RGNX) in Q2 2026: 22 shares worth $264. The stake represents ﹤0.01% of the portfolio and ranks #4357 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in RGNX as recently as Q4 2025.

Global Retirement Partners first reported a position in RGNX in Q4 2019 and has held it in 20 quarters since. The position peaked at $8.37K in Q1 2024. 164 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.

  • Global Retirement Partners held 22 shares of Regenxbio worth $264 as of Q2 2026.
  • Regenxbio was a new Global Retirement Partners position in Q2 2026.
  • Regenxbio made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4357 holding.
  • Global Retirement Partners first reported a position in Regenxbio in Q4 2019 and has held it in 20 quarters since.
  • Global Retirement Partners's Regenxbio position peaked at $8.37K in Q1 2024.
  • 164 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.